Optical imaging

Global Vein Illumination Technologies Market Report 2021: Patient Comfort & Safety Becomes a Higher Priority for Healthcare Givers - Market to Reach $592.8 Million by 2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 18, 2021

Patient Comfort & Safety Becomes a Higher Priority for Healthcare Givers.

Key Points: 
  • Patient Comfort & Safety Becomes a Higher Priority for Healthcare Givers.
  • Vein Illumination Technologies to Reach $592.8 Million
    The global market for Vein Illumination Technologies is projected to reach US$ 592.8 million by the year 2027, trailing a post COVID-19 CAG4R of 28.2% over the analysis period 2020 through 2027.
  • Vein illuminator devices, also called vein finders, use advanced visualizing technologies for aiding healthcare professionals easily locate veins that are hard-to-find.
  • In patients with fragile skin, especially geriatric patients, infants, and obese persons, nurses and doctors cannot easily locate veins, creating the need for vein illumination technologies.

Global Optical Coherence Tomography for Ophthalmology Market 2021-2025 - Global Market Forecast to Grow at a CAGR of 7% During 2021-2025

Retrieved on: 
Thursday, March 11, 2021

DUBLIN, March 11, 2021 /PRNewswire/ -- The "Global Optical Coherence Tomography for Ophthalmology Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 11, 2021 /PRNewswire/ -- The "Global Optical Coherence Tomography for Ophthalmology Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • The optical coherence tomography for ophthalmology market is poised to grow by $270.86 mn during 2021-2025, progressing at a CAGR of 7% during the forecast period.
  • This study identifies the growing focus toward adaptive optics as another of the prime reasons driving the optical coherence tomography for ophthalmology market growth during the next few years.
  • The optical coherence tomography for ophthalmology market analysis includes product segment, end-user segment and geographical landscapes.

World Optical Coherence Tomography for Ophthalmology Market Outlook to 2025 - Increasing Incidences of Ocular Diseases, New Product Differentiation and Increasing Adoption of Handheld OCT Devices - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 9, 2021

The "Global Optical Coherence Tomography for Ophthalmology Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Optical Coherence Tomography for Ophthalmology Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • The optical coherence tomography for ophthalmology market is poised to grow by $270.86 mn during 2021-2025, progressing at a CAGR of 7% during the forecast period.
  • The market is driven by the increasing incidences of ocular diseases, market expansion with new product differentiation, and increasing adoption of hand-held OCT devices.
  • The optical coherence tomography for ophthalmology market analysis includes product segment, end-user segment and geographical landscapes.

Optical Coherence Tomography for Ophthalmology Market by Product, End-users, & Geography (2020-2024) - Technavio

Retrieved on: 
Thursday, December 3, 2020
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201203005811/en/
    Technavio has announced its latest market research report titled Global Optical Coherence Tomography for Ophthalmology Market 2020-2024 (Graphic: Business Wire)
    Worried about the impact of COVID-19 on your Business?
  • The report on the optical coherence tomography for ophthalmology market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The optical coherence tomography for ophthalmology market analysis includes product segment, end-user segment, and geography landscape.
  • The optical coherence tomography for ophthalmology market covers the following areas:

Modulim Announces CE Mark of Clarifi Imaging System for Microvascular Assessment

Retrieved on: 
Wednesday, December 2, 2020

Modulim , the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced today that Clarifi has received CE Mark certification.

Key Points: 
  • Modulim , the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced today that Clarifi has received CE Mark certification.
  • Powered by Spatial Frequency Domain Imaging (SFDI), a patented optical imaging technology, Clarifi is the newest advancement for assessing tissue and microvascular function by quantitatively mapping tissue oxygenation and perfusion at the point-of-care.
  • Obtaining CE marking for the Clarifi Imaging System is a key milestone for Modulim, said David Cuccia, Ph.D., Modulims President and CTO.
  • Clarifi, powered by Spatial Frequency Domain Imaging (SFDI) technology, identifies compromised circulation at the point of care through non-contact rapid microvascular assessment of tissue.

Global Optical Coherence Tomography for Ophthalmology Industry (2020 to 2027) - Market Trends and Drivers - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 29, 2020

The "Optical Coherence Tomography (OCT) for Ophthalmology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Optical Coherence Tomography (OCT) for Ophthalmology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • The publisher brings years of research experience to the 6th edition of this report.
  • The 120-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021.
  • The U.S. Market is Estimated at $192.4 Million, While China is Forecast to Grow at 5.2% CAGR
    The Optical Coherence Tomography (OCT) for Ophthalmology market in the U.S. is estimated at US$192.4 Million in the year 2020.

Research Report: Optical Coherence Tomography For Ophthalmology Market (2020-2024) | The Increasing Incidences Of Ocular Diseases to boost the Market Growth | Technavio

Retrieved on: 
Friday, September 4, 2020

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
  • Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.
  • The increasing incidences of ocular diseases is one of the major factors driving the market.
  • Optical Coherence Tomography for Ophthalmology Market 2020-2024: Segmentation
    Optical Coherence Tomography for Ophthalmology Market is segmented as below:

Fluorescein Angiography Market Size Worth $617.4 Million By 2027: Grand View Research, Inc.

Retrieved on: 
Wednesday, August 26, 2020

However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.

Key Points: 
  • However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.
  • Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions.
  • In addition, the demand for tradition fluorescein angiography systems is still high in developing countries.
  • Grand View Research has segmented the global fluorescein angiography market based on product, technology, application, and region:

Fluorescein Angiography Market Size Worth $617.4 Million By 2027: Grand View Research, Inc.

Retrieved on: 
Wednesday, August 26, 2020

However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.

Key Points: 
  • However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.
  • Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions.
  • In addition, the demand for tradition fluorescein angiography systems is still high in developing countries.
  • Grand View Research has segmented the global fluorescein angiography market based on product, technology, application, and region:

Kubota Vision Demonstrates 3D Imaging Capabilities Using AI on PBOS

Retrieved on: 
Wednesday, July 29, 2020

Kubota Vision Inc. (Kubota Vision), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that the company demonstrated 3D imaging capabilities using artificial intelligence (AI) on our Patient Based Ophthalmology Suite (PBOS), in-home optical coherence tomography (OCT) device.

Key Points: 
  • Kubota Vision Inc. (Kubota Vision), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that the company demonstrated 3D imaging capabilities using artificial intelligence (AI) on our Patient Based Ophthalmology Suite (PBOS), in-home optical coherence tomography (OCT) device.
  • The first fully-functional, working PBOS prototypes have been completed, and the company is currently in the process of further improving the software including 3D imaging capabilities.
  • Ryo Kubota, MD, PhD, Chairman, President and CEO of Kubota Vision Inc., stated, We are excited to share this great news that our PBOS demonstrated 3D imaging capabilities using AI via internet data transfer.
  • Kubota Vision, the Kubota Vision logo and Kubota are registered trademarks or trademarks of Kubota Vision Inc. or Kubota Pharmaceutical Holdings in various jurisdictions.